A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|2|151-159

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.2, 2018-02, pp. : 151-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 160-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

By Maldonado Rafael  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1001-1014

Informa Healthcare

Access to resources Recommend Favorite

Extended-Release Methylphenidate (Ritalin LA)

By Lyseng-Williamson K.A.   Keating G.M.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2251-2259

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 123-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tramadol Extended-Release Tablets

By Hair Philip I.   Curran Monique P.   Keam Susan J.  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2017-2027

Adis International

Access to resources Recommend Favorite